文献速递糖尿病

新发1型糖尿病儿童乳糜泻的早期与晚期组织学确认比较

Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes.
PubMed 文献 · Diabetologia · 2022-04-30

该多中心人群队列研究基于德国/奥地利/瑞士/卢森堡糖尿病前瞻随访登记(DPV),纳入1995年至2021年6月诊断的≤18岁新发1型糖尿病且筛查抗tTGA升高者,比较糖尿病病程1年以上时,6个月内与6-36个月组织学确认乳糜泻者的结局,发现两组HbA1c、心血管风险标志物、急性并发症及抗tTGA正常化比例无差异,延迟确认对生长无负面影响,提示无症状新发1型糖尿病患儿的组织学确认可推迟。

要点

  • 在92278例1型糖尿病患儿中,26952例(29.2%)有糖尿病起病时抗tTGA数据,其中2340例(8.7%)抗tTGA升高。
  • 533例筛查阳性者(22.8%)有活检记录,444例有组织学确认乳糜泻。
  • 411例糖尿病36个月内活检证实乳糜泻并有随访数据者中,264例(64.2%)在6个月内确认,147例(35.8%)在6-36个月确认。

核心结论

  • 研究提示,无症状新发1型糖尿病个体的乳糜泻组织学确认可以推迟。

研究设计与样本

  • 多中心人群队列研究,基于德国/奥地利/瑞士/卢森堡糖尿病前瞻随访登记(DPV)。
  • 纳入1995年至2021年6月诊断的≤18岁1型糖尿病患儿,且糖尿病起病时筛查抗tTGA升高。
  • 比较糖尿病病程>1年时,6个月内组织学确认乳糜泻者与6-36个月确认者的结局。

主要发现

  • 92278例1型糖尿病患儿中,26952例(29.2%)有起病时抗tTGA数据,2340例(8.7%)抗tTGA升高。
  • 筛查阳性者较阴性者更年轻(中位年龄9.0 vs 9.8岁,p<0.001)且女性比例更高(53.1% vs 44.4%,p<0.001)。
  • 533例筛查阳性者(22.8%)有活检记录,其中444例有组织学确认乳糜泻。
  • 411例糖尿病36个月内活检证实乳糜泻并有随访数据者中,264例(64.2%)在6个月内确认,147例(35.8%)在6-36个月确认。
  • 随访时(中位糖尿病病程分别为5.3年与5.1年),估计中位HbA1c(62.8 mmol/mol vs 62.2 mmol/mol [7.9% vs 7.8%])、心血管风险标志物(血脂、微量白蛋白尿率、血压)、急性糖尿病并发症(糖尿病酮症酸中毒、严重低血糖)率及抗tTGA达正常范围的比例在两组间无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Screening for coeliac disease in asymptomatic children with new-onset type 1 diabetes is controversial. The aim of this study was to analyse whether the confirmation of coeliac disease in children with new-onset type 1 diabetes and positive screening results can be postponed. METHODS: This was a multicentre population-based cohort study based on the German/Austrian/Swiss/Luxembourgian Prospective Diabetes Follow-up Registry (Diabetes Patienten Verlaufsdokumentation [DPV]). Participants aged ≤18 years diagnosed with type 1 diabetes between 1995 and June 2021 and with elevated IgA tissue transglutaminase antibodies (anti-tTGA) at diabetes onset on screening for coeliac disease were included. We compared outcomes of participants with a diabetes duration of more than 1 year between those in whom coeliac disease was confirmed histologically within the first 6 months and those in whom coeliac disease was confirmed between 6 and 36 months after diabetes diagnosis. RESULTS: Of 92,278 children and adolescents with a diagnosis of type 1 diabetes, 26,952 (29.2%) had documented anti-tTGA data at diabetes onset. Of these, 2340 (8.7%) had an elevated anti-tTGA level. Individuals who screened positive were younger (median age 9.0 vs 9.8 years, p<0.001) and more often female (53.1% vs 44.4%, p<0.001). A total of 533 participants (22.8% of those who screened positive) had a documented biopsy, of whom 444 had documented histological confirmation of coeliac disease. Of 411 participants with biopsy-proven coeliac disease within the first 36 months of diabetes and follow-up data, histological confirmation was performed in 264 (64.2%) within the first 6 months and in 147 (35.8%) between 6 and 36 months after diabetes onset. At follow-up (median diabetes duration 5.3 years and 5.1 years, respectively), estimated median HbA1c levels (62.8 mmol/mol vs 62.2 mmol/mol [7.9% vs 7.8%]), cardiovascular risk markers (lipids, rate of microalbuminuria, blood pressure), rates of acute diabetes complications (diabetic ketoacidosis, severe hypoglycaemia) and the proportions of participants reaching anti-tTGA levels within the normal range did not differ between groups. Participants with delayed histological confirmation of coeliac disease showed no negative effects on growth or weight gain during the observation period. CONCLUSIONS: Our study suggests that the histological confirmation of coeliac disease in asymptomatic individuals with new-onset type 1 diabetes could be postponed.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Kamrath C, Tittel SR, Dunstheimer D, et al. Early vs late histological confirmation of coeliac disease in children with new-onset type 1 diabetes. Diabetologia. 2022. PMID: 35488926. doi:10.1007/s00125-022-05701-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。